|
Volumn 8 Suppl 1, Issue , 2004, Pages
|
Association of taxanes and radiotherapy: preclinical and clinical studies;Associations de taxanes et de radiothérapie: données précliniques et cliniques.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DOCETAXEL;
PACLITAXEL;
RADIOSENSITIZING AGENT;
TAXOID;
ANIMAL;
BRAIN TUMOR;
CELL CULTURE;
COMPARATIVE STUDY;
DISEASE FREE SURVIVAL;
DRUG EFFECT;
ESOPHAGUS TUMOR;
FEMALE;
HEAD AND NECK TUMOR;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
NEOPLASM;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
RADIATION DOSE;
REVIEW;
TIME;
ANIMALS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BRAIN NEOPLASMS;
CARCINOMA, NON-SMALL-CELL LUNG;
CELLS, CULTURED;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
ESOPHAGEAL NEOPLASMS;
FEMALE;
HEAD AND NECK NEOPLASMS;
HUMANS;
LUNG NEOPLASMS;
MALE;
NEOPLASMS;
PACLITAXEL;
RADIATION-SENSITIZING AGENTS;
RADIOTHERAPY DOSAGE;
TAXOIDS;
TIME FACTORS;
TUMOR CELLS, CULTURED;
|
EID: 13744263831
PISSN: 12783218
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (18)
|
References (119)
|